Skip to main content
Sign In

We are a nationally recognized department of Ophthalmology.

Othamology Banner Image

Jeffrey L Olson, MD

Associate Professor

Vitreoretinal Diseases and Surgery
Department of Ophthalmology
University of Colorado School of Medicine
Anschutz Medical Campus
1675 Aurora Court, Mail Stop F-731
Aurora, CO  80045

Appointments:  (720) 848-2020

 Curriculum Vitae

Jeffrey L Olson, M.D. is an Associate Professor in the Department of Ophthalmology and is a specialist in the medical and surgical management of retinal diseases such as macular degeneration, diabetic retinopathy and retinal detachment.   He is an active member in the American Academy of Ophthalmology, the American Society of Retina Specialists, and the Association for Research in Vision and Ophthalmology.  His research interests are focused on translational interventions for retinal photoreceptor degeneration, novel microsurgical instrumentation, and treatments for ischemic retinal diseases. He recently received the Team Science Award from the Colorado Clinical and Translational Sciences Institute, as well as two grants from the Colorado Bioscience Program to support this research.

After completing his undergraduate studies at the University of Virginia, Dr. Olson received his medical degree from the University of Colorado, and completed his Internship at the Marshfield Clinic.  He then completed his Ophthalmology Residency and Vitreoretinal Fellowship at the University of Colorado Health Sciences Center in Denver.


Macular degeneration, diabetic eye disease, retinal detachment, retinal vascular occlusion, uveitis, proliferative vitreoretinopathy, macular hole, epiretinal membrane.


Retinal biomicroscopy, fluoroscein angiography, posterior segment ultrasound, optical coherence tomography, intravitreal injections of Avastin/Lucentis/Steroid, retinal laser, vitrectomy, scleral buckling, epiretinal membrane peeling, macular hole closure.


Anti-PDGF Combination Injection for New Wet Macular Ocriplasmin for Injection for Wet Macular Degeneration and Vitreomacular Adhesion

HARBOR - high dose ranibizumab for wet-AMD

RISE - ranibizumab for DMEDegeneration


  • Medical School:  University of Colorado Health Sciences Center
  • Residency:  Ophthalmology, University of Colorado School of Medicine
  • Fellowship: Vitreoretinal Diseases and Surgery, University of Colorado School of Medicine


  • 2007  Department of Ophthalmology Academic Teaching Award
  • 2010  Colorado Clinical and Translational Sciences Institute, Team Science Award
  • 2011  Rhett Buckler Award, American Society of Retinal Specialists Annual Meeting, Film Festival Award Winner
  • 2012  Film Festival Award Winner, American Society of Cataract and Refractive Surgery Annual Meeting
  • 2012  Inventor of the Year, University of Colorado Anschutz Medical Campus
  • 2013  Pan-American Ophthalmological Foundation Research Incentive Award in Retina (co-author)
  • 2014  Honor Award, American Society of Retinal SpecialistsHonor Award, American Society of Retinal Specialists